DUBLIN--(BUSINESS WIRE)--The "Synthetic Biology Market: By Tool; By Technology; By Application & By Geography - Forecast (2017-2023)" report has been added to Research and Markets' offering.
The market report provides analysis of synthetic biology applications in environmental, medical and industrial sectors. Rising demand for improved drugs and vaccines has been attracting investments globally into the healthcare sector. The synthetic biology market is thus set to witness significant growth in coming years owing to the strong investments from both public and private sector.
Market Drivers
- Strong Investments in Synthetic Biology
- Developments in Production of Bio-Based Chemicals and Fuels
- Rising Demand for Improved Drugs and Vaccines
- Advancement in Molecular Biology
- Wide Spread Application of Synthetic Biology
Market Challenges/Constraints
- Rising Biosecurity Issues
- Ethical Concerns and Stringent Regulations
Synthetic biology exactly deals with the design and fabrication of biological components that does not exist and also the redesign of the existing biological components. It creates an artificial life using unnatural components. It also uses natural components and assembles them into a system that acts unnaturally.
Synthetic biology majorly involves the activities such as DNA coding, synthetic genes, bioinformatics, processing of various biological components, genome engineering and so on.
Synthetic Biology market is segmented based on tools, technology, applications and geography. Tools considered in the report are Xeno-Nucleic Acids (Xnas), Chassis Organisms, Oligonucleotides, Cloning Technology Kits and Enzymes. Researchers and companies involved in synthetic biology are synthesizing enzymes with high activity to produce products with optimal yields and effectiveness.
Key Topics Covered:
1. Synthetic Biology Market Overview
2. Synthetic Biology Market Executive Summary
3. Synthetic Biology Market Landscape
4. Synthetic Biology Market Forces
5. Synthetic Biology Market - Strategic Analysis
6. Synthetic Biology Market - By Tool
7. Synthetic Biology Market - By Technology
8. Synthetic Biology Market - By Application
9. Synthetic Biology Market - By Geography
10. Synthetic Biology Market Entropy
11. Synthetic Biology Market - Company Profiles
- Ingenza Ltd (U.K.)
- Intrexon Corporation (U.S)
- Ziopharm Oncology Inc (U.S)
- Cargill Incorporated (U.S.)
- Novozymes (Denmark)
- OriGene Technologies, Inc (U.S.)
- Green Biologics Limited (U.K.)
- Evolva (Switzerland)
- Codexis, Inc. (U.S.)
- Halozyme Inc. (U.S.)
- Integrated DNA Technologies, Inc. (U.S.)
- Thermo Fisher Scientific, Inc. (U.S.)
- Algenol Biotech (U.S.)
- Amyris Inc (U.S.)
- BioAmber Inc (Canada)
For more information about this report visit https://www.researchandmarkets.com/research/b4ld5f/synthetic_biology
